QA: Alzamend Neuro Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001677077_2023_Alzamend_Neuro_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001677077, Alzamend Neuro Inc.

  xvar xval
0 AssetsCurrent 14,413,534
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 102,909
3 remainder_Assets 0
4 LiabilitiesCurrent 1,164,932
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,118,221
9 ResearchAndDevelopmentExpense 5,201,314
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -42,524
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 14,516,443
1 Liabilities 1,164,932
2 Expenses 12,319,535
3 Revenues 0
4 StockholdersEquity 13,351,511
5 NetIncome -12,362,059
6 ComprehensiveNetIncome -12,362,059
7 BaseVar 14,021,717
8 EconomicCapitalRatio 1.35

Edgar->Model Mapping

Feature Distribution

Change over Time